Posttransplant Lymphoproliferative Disorder
📧 Sign up to get email alerts when something new happens for Posttransplant Lymphoproliferative Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy [Phase 2]
Phase 2 clinical trial evaluating risk-stratified sequential treatment of post-transplant lymphoproliferative disorder using rituximab subcu…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Risk Stratified Sequential Treatment for CD20-positive PTLD [Phase 2]
Phase 2 clinical trial update on risk-stratified sequential treatment for CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD).